Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac for post-tonsillectomy pain in children
NCT03453541Phase 4Terminated
- Sponsor
- Albany Medical College
- Start
- Nov 2017
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ketorolac in postoperative pain, sponsored by Albany Medical College. Primary endpoint: Rebleeding rate requiring operative intervention at 2 weeks. Started Nov 2017; status: terminated.
02
Drugs
ketorolac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03453541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03453541.